Literature DB >> 33652684

A Properly Balanced Reduction Diet and/or Supplementation Solve the Problem with the Deficiency of These Vitamins Soluble in Water in Patients with PCOS.

Małgorzata Szczuko1, Iwona Szydłowska2, Jolanta Nawrocka-Rutkowska2.   

Abstract

Polycystic ovary syndrome (PCOS) is an increasingly common problem for women in the reproductive age throughout the entire world. A reduction diet with a low glycaemic index (GI) has proved to support the treatment of PCOS. The aim of the study was to analyse the influence of the diet on the level of vitamins soluble in water. The study included 55 women, 40 of which suffered from PCOS (identified by means of the Rotterdam Criteria) and 15 healthy women of the Caucasian race. The level of vitamins before and after the dietary intervention was measured. The diet was a reduction diet with a reduced glycaemic index (GI). Biochemical analyses were made on the basis of liquid chromatography-Infinity 1260 Binary liquid chromatography (LC) Agilent Technology. The level of vitamins in the serum was analysed together with the consumption before and after the dietary intervention. A higher level of vitamin C in the plasma was observed before and after the dietary intervention in the PCOS group in comparison to the control group despite the lower intake of this vitamin in the PCOS group. The remaining vitamins were at a comparable or lower level (B1, B3, B5, B6 and B12). After the dietary intervention, only B1 and B9 were at a clearly lower level (a trend of p = 0.093 and p = 0.085). A properly balanced reduction diet with reduced GI improves the supply of vitamins in women with PCOS. An additional recommendation should be the additional supplementation of B1, niacinamide and the combination of folates with inositol. The level of vitamin C in the plasma may not be a good marker of its supply in the PCOS group.

Entities:  

Keywords:  PCOS; ascorbic acid; folates; niacin; thiamine; vitamins

Year:  2021        PMID: 33652684      PMCID: PMC7996738          DOI: 10.3390/nu13030746

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  43 in total

Review 1.  N1-Methylnicotinamide: An Anti-Ovarian Aging Hormetin?

Authors:  Hamid Reza Nejabati; Kathrin Schmeisser; Vahideh Shahnazi; Deniz Samimifar; Yousef Faridvand; Zahra Bahrami-Asl; Nazila Fathi-Maroufi; Saba Nikanfar; Mohammad Nouri
Journal:  Ageing Res Rev       Date:  2020-07-22       Impact factor: 10.895

Review 2.  Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews.

Authors:  Emily W Gilbert; Chau T Tay; Danielle S Hiam; Helena J Teede; Lisa J Moran
Journal:  Clin Endocrinol (Oxf)       Date:  2018-09-18       Impact factor: 3.478

Review 3.  Thiamine and Cardiovascular Disease: A Literature Review.

Authors:  James J DiNicolantonio; Jing Liu; James H O'Keefe
Journal:  Prog Cardiovasc Dis       Date:  2018-01-31       Impact factor: 8.194

Review 4.  Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.

Authors:  Surapon Tangvarasittichai
Journal:  World J Diabetes       Date:  2015-04-15

5.  Metabolic pathways of oleic and palmitic acid are intensified in PCOS patients with normal androgen levels.

Authors:  Małgorzata Szczuko; Marta Zapałowska-Chwyć; Arleta Drozd; Dominika Maciejewska; Andrzej Starczewski; Ewa Stachowska
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-09-08       Impact factor: 4.006

Review 6.  Vitamin-mediated immune regulation in the development of inflammatory diseases.

Authors:  Hidehiko Suzuki; Jun Kunisawa
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2015       Impact factor: 2.895

7.  Nicotinamide and its metabolite N1-Methylnicotinamide alleviate endocrine and metabolic abnormalities in adipose and ovarian tissues in rat model of Polycystic Ovary Syndrome.

Authors:  Hamid Reza Nejabati; Nasser Samadi; Vahideh Shahnazi; Aynaz Mihanfar; Amir Fattahi; Zeinab Latifi; Zahra Bahrami-Asl; Leila Roshangar; Mohammad Nouri
Journal:  Chem Biol Interact       Date:  2020-04-13       Impact factor: 5.192

8.  Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.

Authors:  Ying Xiong; Ce Bian; Xiaojuan Lin; Xiaoli Wang; Kehui Xu; Xia Zhao
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

9.  Association of three missense mutations in the homocysteine-related MTHFR and MTRR gene with risk of polycystic ovary syndrome in Southern Chinese women.

Authors:  Wanqin Feng; Yan Zhang; Yuan Pan; Yi Zhang; Minjuan Liu; Yuxin Huang; Yuanling Xiao; Wenyu Mo; Junjie Jiao; Xiaoyang Wang; Dan Tian; Lixia Yang; Ying Ma
Journal:  Reprod Biol Endocrinol       Date:  2021-01-07       Impact factor: 5.211

10.  The Effect of Metformin Treatment on the Serum Levels of Homocysteine, Folic Acid, and Vitamin B12 in Patients with Polycystic Ovary Syndrome.

Authors:  Sedigheh Esmaeilzadeh; Maryam Gholinezhad-Chari; Reza Ghadimi
Journal:  J Hum Reprod Sci       Date:  2017 Apr-Jun
View more
  2 in total

1.  Metabolomic Profiling of Poor Ovarian Response Identifies Potential Predictive Biomarkers.

Authors:  Haixia Song; Qin Qin; Caixia Yuan; Hong Li; Fang Zhang; Lingling Fan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-23       Impact factor: 5.555

2.  Vitamin B3 (niacin), B6, C, and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome

Authors:  Andon Hestiantoro; Brilliant Putri Kusuma Astuti; Ericko Ongko Joyo; Ririn Rahmala Febri; Vita Silvana; Raden Muharam
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.